ITGB2 and rheumatoid arthritis: While the increase in cellular marker of CD18 and inflammatory diseases, including rheumatoid arthritis, is unclear in humans, particularly in patients with RA, this marker is associated with an increase; however, the endogenous or exogenous origin to express CD18 is not fully understood.